Axogen, Inc. Earnings Per Share (Diluted)
Axogen, Inc. (AXGN) reported Earnings Per Share (Diluted) of -$0.03 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-29
- Axogen, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.03, a 400.00% decline year-over-year.
- Axogen, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.38.
- Axogen, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.28, a 3005.55% decline year-over-year.
- Axogen, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.01.
- Axogen, Inc. earnings per share, diluted for fiscal 2025 was -$0.34.
- Axogen, Inc. earnings per share, diluted for fiscal 2024 was -$0.23.
- Axogen, Inc. earnings per share, diluted for fiscal 2023 was -$0.51.
- Axogen, Inc. earnings per share, diluted for fiscal 2022 was -$0.69.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.03 10-Q · filed 2026-07-29 | -$0.40 10-Q · filed 2026-07-29 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2026-03-31 | -$0.38 10-Q · filed 2026-04-28 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2025-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$0.34 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.01 10-Q · filed 2025-10-29 | $0.03 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$0.06 10-Q · filed 2025-10-29 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2025-06-30 | $0.01 10-Q · filed 2026-07-29 | -$0.07 10-Q · filed 2026-07-29 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-07-29 |
| 2025-03-31 | -$0.08 10-Q · filed 2026-04-28 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.23 10-K · filed 2026-02-24 |
| 2024-09-30 | -$0.04 10-Q · filed 2025-10-29 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-10-29 | -$0.24 10-Q · filed 2025-10-29 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-06-30 | -$0.04 10-Q · filed 2025-08-05 | -$0.20 10-Q · filed 2025-08-05 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-03-31 | -$0.15 10-Q · filed 2025-05-08 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.51 10-K · filed 2026-02-24 |
| 2023-09-30 | -$0.10 10-Q · filed 2024-11-07 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.42 10-Q · filed 2024-11-07 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-06-30 | -$0.16 10-Q · filed 2024-08-08 | -$0.32 10-Q · filed 2024-08-08 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-03-31 | -$0.17 10-Q · filed 2024-05-02 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.69 10-K · filed 2025-02-26 |
| 2022-09-30 | -$0.10 10-Q · filed 2023-11-07 | -$0.29 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.56 10-Q · filed 2023-11-07 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-06-30 | -$0.18 10-Q · filed 2023-08-08 | -$0.46 10-Q · filed 2023-08-08 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-03-31 | -$0.27 10-Q · filed 2023-05-09 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2021-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.65 10-K · filed 2024-03-05 |
| 2021-09-30 | -$0.17 10-Q · filed 2022-11-08 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.53 10-Q · filed 2022-11-08 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-03-14 |
| 2021-06-30 | -$0.19 10-Q · filed 2022-08-05 | -$0.36 10-Q · filed 2022-08-05 | -$0.51 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-03-14 |
| 2021-03-31 | -$0.16 10-Q · filed 2022-05-05 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2023-03-14 |
| 2020-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.60 10-K · filed 2023-03-14 |
| 2020-09-30 | -$0.04 10-Q · filed 2021-11-04 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.45 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$0.20 10-Q · filed 2021-08-05 | -$0.41 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | -$0.74 10-K · filed 2022-02-25 | |||
| 2011-06-30 | $0.06 10-Q/A · filed 2011-09-09 | $0.27 10-Q/A · filed 2011-09-09 | ||
| 2010-06-30 | -$0.05 10-Q/A · filed 2011-09-09 | -$0.11 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |